Point72 Europe (London) LLP Procept Bio Robotics Corp Transaction History

Point72 Europe (London) LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$45.73 - $69.19 $2.8 Million - $4.23 Million	-61,200 Reduced 19.1%	259,231 $15.8 Million
Q1 2024 May 15, 2024	SELL	$40.38 - $50.75 $8.47 Million - $10.6 Million	-209,640 Reduced 39.55%	320,431 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $3.08 Million - $5.37 Million	123,800 Added 30.47%	530,071 $22.2 Million
Q3 2023 Nov 14, 2023	BUY	$30.02 - $38.81 $12.2 Million - $15.8 Million	406,271 New	406,271 $13.3 Million

267

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.34B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.